Quantcast

Latest multiple sclerosis Stories

Tuberculosis Vaccine Cure For MS
2013-12-05 11:34:05

Brett Smith for redOrbit.com - Your Universe Online A new preliminary study from a team of Italian researchers has found that a vaccine used to thwart tuberculosis outside the US could be used to treat multiple sclerosis (MS). In the study, which was published in the journal Neurology, scientists found people who had early symptoms of MS and MRI scans pointing to the development of the neurological condition benefited from receiving an injection of Bacille Calmette-Guérin, which is...

2013-11-30 23:01:17

http://www.DailyGossip.org reveals that multiple sclerosis is a complex condition that causes numerous symptoms. The magazine publishes a review to the Multiple Sclerosis Treatment, the newest natural remedy that provides fast symptoms relief. Denver, CO (PRWEB) November 30, 2013 According to DailyGossip.org review published on November 30, multiple sclerosis is a condition that can be developed by any individual. The "Multiple Sclerosis Treatment" review on DailyGossip.org...

2013-11-22 23:29:44

Primary Message To MS Patients and Practitioners is Endovascular Treatment for CCSVI Should Only Be Conducted in the Context of a Randomized, Double-Blinded Controlled Study New York, New York (PRWEB) November 22, 2013 Multiple sclerosis (MS) is a disease of uncertain etiology characterized by demyelinating lesions affecting the central nervous system. In 2009, Dr. Paolo Zamboni et al described an association between MS and extra cranial venous outflow restrictive lesions detected by...

2013-11-21 23:20:17

Reportbuyer.com just published a new market research report: Multiple Sclerosis: KOL Insight. London (PRWEB) November 21, 2013 The multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen’s Tecfidera (dimethyl fumarate) has revolutionised multiple sclerosis treatment in the US, eroding significant market share from older therapies. However, patent concerns has stalled Tecfidera’s launch in Europe. Genzyme have taken advantage of this delay with...

2013-11-14 23:04:03

Reportbuyer.com just published a new market research report: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules. London (PRWEB) November 14, 2013 The multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen’s Tecfidera has revolutionised multiple sclerosis treatment in the U.S., eroding significant market share from older therapies. However, patent concerns has stalled Tecfidera’s launch in Europe. Genzyme have taken advantage of...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related